An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

AstraZeneca's $1.3B bet yields 2nd phase 3 blood pressure win

The phase 3 win for baxdrostat boost AstraZeneca's attempts to turn the molecule’s long half-life into a competitive advantage.
Nick Paul Taylor Oct 7, 2025 4:01am
Wall Street stock exchange new York shares market

MapLight illuminates $262M IPO plans to fund Cobenfy competitor

Oct 7, 2025 6:30am
How do you get pharmaceutical treatments where theyre needed most

How to get pharmaceutical treatments where they’re needed most.

Oct 6, 2025 8:00am
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

James Wilson's GEMMABio launches new gene therapy biotech

Oct 7, 2025 10:00am
Accelerate clinical trials with a connected financial ecosystem

Accelerate clinical trials with a connected financial ecosystem

Oct 6, 2025 8:00am
Fierce Fundraising Tracker image 2025

Fierce Biotech Fundraising Tracker: Torl; Cartography & more

Oct 7, 2025 7:30am
More News

Spanish oncology group infuses AI into breast cancer trials

Oct 7, 2025 6:05am

Fierce Biotech Layoff Tracker 2025: Pharming, Bolt & more

Oct 6, 2025 1:30pm

TCG Crossover hauls in $1.3B for 3rd investment fund

Oct 6, 2025 11:14am

AstraZeneca, Algen Biotechnologies pen $555M AI pact

Oct 6, 2025 8:00am